sb 206553 has been researched along with sulpiride in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abramyan, A; Akano, EO; Aubé, J; Ferrer, M; Frankowski, KJ; Free, RB; Gandhi, D; Hu, X; Keck, TM; Moritz, AE; Shi, L; Sibley, DR; Southall, N; Steiner, J; Weiner, WS | 1 |
1 other study(ies) available for sb 206553 and sulpiride
Article | Year |
---|---|
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D
Topics: Animals; CHO Cells; Cricetulus; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Hep G2 Cells; Humans; Induced Pluripotent Stem Cells; Male; Mice; Mice, Inbred C57BL; Protein Structure, Secondary; Receptors, Dopamine D3 | 2020 |